Health Affairs, 24, no. 4 (2005): 915-926 doi: 10.1377/hlthaff.24.4.915 © 2005 by Project HOPE	New Online   In the News: Health Spending Slowdown   New Issue: Chronic Illness   Top 10 Posts for 2008   Daschle: What to Expect?   Obama on Health IT

This Article Full Text (HTML) Reprint (PDF) Supplemental Exhibit Sources Submit a response to this article Alert me when this article is cited Alert me when Comments are posted Alert me if a correction is posted Services E-mail this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Alert me to new issues of the journal Add to My Personal Archive Download to Citation Manager Reprints & Permissions Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (11) Citing Articles via Google Scholar Google Scholar Articles by Cohen, D. A. Articles by Farley, T. A. Search for Related Content PubMed Articles by Cohen, D. A. Articles by Farley, T. A. Related Collections Access To Care Ethical Issues Health Promotion/Disease Prevention AIDS/HIV Legal/Regulatory Issues Managed Care - Medicare Health Spending Politics Consumer Issues

HIV Prevention

Cost-Effective Allocation Of Government Funds To Prevent HIV Infection

Relative to the magnitude of the epidemic, government funds available for HIV prevention are scarce. To optimize use of funds, we applied a mathematical model of the cost of HIV prevention interventions using national data on HIV risk-group size and HIV prevalence. This procedure suggested an allocation of funds across nine interventions to potentially prevent an estimated 20,000 infections annually, compared with the estimated 7,300 infections potentially prevented through four interventions now recommended by the Centers for Disease Control and Prevention (CDC). The optimal allocation will involve a combination of intensive interventions for high-prevalence populations and inexpensive large-scale interventions for lower-prevalence populations.

                      What's this?

This article has been cited by other articles:

				D. C. D. Jarlais and S. Semaan HIV Prevention for Injecting Drug Users: The First 25 Years and Counting Psychosom Med, June 1, 2008; 70(5): 606 - 611. [Abstract] [Full Text] [PDF]

				D. R. Holtgrave, J. F. McGuire, and J. Milan Jr The Magnitude of Key HIV Prevention Challenges in the United States: Implications for a New National HIV Prevention Plan Am J Public Health, July 1, 2007; 97(7): 1163 - 1167. [Abstract] [Full Text] [PDF]

				D. J. Koo, E. M. Begier, M. H. Henn, K. A. Sepkowitz, and S. E. Kellerman HIV Counseling and Testing: Less Targeting, More Testing Am J Public Health, June 1, 2006; 96(6): 962 - 964. [Full Text] [PDF]

				B. P. Linas, H. Zheng, E. Losina, R. P. Walensky, and K. A. Freedberg Assessing the Impact of Federal HIV Prevention Spending on HIV Testing and Awareness Am J Public Health, June 1, 2006; 96(6): 1038 - 1043. [Abstract] [Full Text] [PDF]

				D. A. Cohen, S.-Y. Wu, and T. A. Farley HIV PREVENTION CASE MANAGEMENT IS NOT COST-EFFECTIVE Am J Public Health, March 1, 2006; 96(3): 400 - 401. [Full Text] [PDF]